Abhinav Deol, MD, Oncology, Detroit, MI, Karmanos Cancer Center

AbhinavDeolMD

Oncology Detroit, MI

Hematologic Oncology

Hematology/Oncology/ BMT, Karmanos Cancer Institute. Associate Professor, Department of Oncology, Wayne State University

Overview of Dr. Deol

Dr. Abhinav Deol is an oncologist in Detroit, MI and is affiliated with multiple hospitals in the area, including Karmanos Cancer Center, DMC - Detroit Receiving Hospital, and DMC Harper University Hospital. He received his medical degree from Government Medical College Amritsar and has been in practice 17 years. Dr. Deol accepts several types of health insurance, listed below. He is one of 31 doctors at DMC - Detroit Receiving Hospital and one of 43 doctors at DMC Harper University Hospital who specialize in Oncology. He also speaks multiple languages, including Hindi, Punjabi, and Urdu.

Education & Training

  • Wayne State University School of Medicine
    Wayne State University School of MedicineFellowship, Hematology/Oncology, 2007 - 2010
  • Wayne State University School of Medicine
    Wayne State University School of MedicineResidency, Internal Medicine, 2004 - 2007
  • Government Medical College Amritsar
    Government Medical College AmritsarClass of 2000

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2007 - 2023
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Ixazomib or Lenalidomide Maintenance Following Autologous Stem Cell Transplantation and Ixazomib, Lenalidomide, and Dexamethasone (IRD) Consolidation in Patients with ...
    Abhinav Deol, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Use of Thymoglobulin with Lower Dose of Busulfan Results in Less Acute Gvhd Following Unrelated Donor Allogeneic Stem Cell Transplantation for AML without Affecting Re...
    Abhinav Deol, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Characteristics and Outcomes of Patients Who Did Not Develop CRS after Axicabtagene Ciloleucel for Relapsed/Refractory Large B-Cell Lymphoma: Results from the US Lymph...
    Abhinav Deol, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Ixazomib-Lenalidomide-Dexamethasone (IRd) Consolidation Following Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Large Multi... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Protmune, a Next-Generation Graft for GvHD Prophylaxis in Allogeneic Hematopoietic Cell Transplantation: 1-Year Safety and Efficacy Phase 1 DataClinically Relevant Abs... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Axicabtagene Ciloleucel (Axi-cel) CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real World ExperienceClinically Re... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Professional Memberships

  • American Society of Hematology
    Member
  • American Society of Blood and Marrow Transplantation
    Member
  • American Society of Clinical Oncology
    Member

Other Languages

  • Hindi, Punjabi, Urdu

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    BCBS Blue Card PPO
    BCBS Illinois PPO
    BCBS Texas BlueChoice
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Cofinity PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Kaiser Permanente
    Multiplan PHCS PPO
    Multiplan PPO
    PriorityHealth HMO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment